28 August, 2014 00:26 IST
News
Dr Reddys gets USFDA nod for Sildenafil tablets
Source: IRIS (19-NOV-12)
Comments  |  Post Comment

Dr Reddys Laboratories, an integrated global pharmaceutical company,  announced that it has launched Sildenafil tablets (20 mg), a bioequivalent generic version of Revatio (Sildenafil) tablets in the US market.

It has received approval by the United States Food & Drugs Administration (USFDA) for ANDA Sildenafil tablets.

The Revatio brand had US sales of approximately USD 338.67 million for the most recent 12 months ending September 2012 according to IMS health.

Shares of the company gained Rs 16, or 0.91%, to trade at Rs 1,773.35. The total volume of shares traded was 755 at the BSE (9.32 a.m., Monday).



Dr Reddy`S Laboratories Limited   (Q,N,C,F)*


Live News
Brown Shoe Q2 earnings rise, beat estimates - 27-Aug-2014 20:00
Isle Of Capri Casinos Q1 loss narrows - 27-Aug-2014 19:51
Brown Forman Q1 profit rises - 27-Aug-2014 19:35
RBI asks FIIs to take approval for further investment in UPL - 27-Aug-2014 19:26
FII, DII remain net buyers in equities - 27-Aug-2014 19:16
Bio Reference Laboratories Q3 earnings beat estimates - 27-Aug-2014 19:15
Bob Evans swings to quarterly loss - 27-Aug-2014 19:06
Chicos Fas Q2 earnings plunge, miss estimates - 27-Aug-2014 18:57
Tiffany Q2 profit rise beats estimate - 27-Aug-2014 18:52
Express Q2 earnings plunge as sales, margins fall - 27-Aug-2014 18:44
10-year G-sec yield fall marginally to 8.76% - 27-Aug-2014 18:20
more...
* Q - Quote , N - News , C - Chart , F - Financials
Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type   ptmgdx into this box
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Forums  |   E-mail  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer